Traws Pharma, Inc (TRAW) insider trading
Every open-market stock purchase and sale by Traws Pharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $4M over the last 12 months (1 buy).
- Last insider buy: Orbimed Advisors LLC (10% owner), $3M, 6 months ago.
Last 12 months: insiders bought $4M (1 buy) and sold $0 (0 sales). Last close $0.66 on Jul 16, 2026.
Recent TRAW insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 9, 2026 | John Harold Leaman (Insider) | Bought (not open market) | — |
| Jul 9, 2026 | Iain D. Dukes (CEO) | Bought (not open market) | — |
| Jul 9, 2026 | Nikolay Savchuk (COO) | Bought (not open market) | — |
| Jul 9, 2026 | Werner Cautreels (Insider) | Bought (not open market) | — |
| Jul 9, 2026 | Charles David Pauza (C-suite exec) | Bought (not open market) | — |
| Jul 9, 2026 | Trafford Clarke (Insider) | Bought (not open market) | — |
| Jul 9, 2026 | Robert Redfield (C-suite exec) | Bought (not open market) | — |
| Jul 9, 2026 | Charles Nolan Parker (CFO) | Bought (not open market) | — |
| Jul 9, 2026 | Jack E Stover (Insider) | Bought (not open market) | — |
| Jul 9, 2026 | Mary Teresa Shoemaker (Insider) | Bought (not open market) | — |
| Apr 16, 2026 | Orbimed Advisors LLC (10% owner) | Bought | $3M |
| Apr 16, 2026 | Orbimed Advisors LLC (10% owner) | Bought | $1M |
| Mar 8, 2026 | Robert Redfield (C-suite exec) | Bought (not open market) | — |
| Mar 8, 2026 | Nikolay Savchuk (COO) | Bought (not open market) | — |
| Mar 8, 2026 | Mary Teresa Shoemaker (Insider) | Bought (not open market) | — |
| Mar 8, 2026 | John Harold Leaman (Insider) | Bought (not open market) | — |
| Mar 8, 2026 | Charles Nolan Parker (CFO) | Bought (not open market) | — |
| Mar 8, 2026 | Werner Cautreels (Insider) | Bought (not open market) | — |
| Mar 8, 2026 | Iain D. Dukes (CEO) | Bought (not open market) | — |
| Mar 8, 2026 | Trafford Clarke (Insider) | Bought (not open market) | — |
| Mar 8, 2026 | Charles David Pauza (C-suite exec) | Bought (not open market) | — |
| Mar 8, 2026 | Jack E Stover (Insider) | Bought (not open market) | — |
| Dec 12, 2025 | Charles Nolan Parker (CFO) | Bought (not open market) | — |
| Dec 12, 2025 | Nikolay Savchuk (COO) | Bought (not open market) | — |
| Dec 12, 2025 | Nikolay Savchuk (COO) | Bought (not open market) | — |
Who's trading TRAW
- Werner Cautreels, Insider: other filings, last Jul 9, 2026
- Trafford Clarke, Insider: other filings, last Jul 9, 2026
- Iain D. Dukes, Chair: other filings, last Jul 9, 2026
- Robert Redfield, C-suite exec: other filings, last Jul 9, 2026
- Jack E Stover, Insider: other filings, last Jul 9, 2026
- Nikolay Savchuk, COO: other filings, last Jul 9, 2026
- Mary Teresa Shoemaker, Insider: other filings, last Jul 9, 2026
- John Harold Leaman, Insider: other filings, last Jul 9, 2026
- Charles Nolan Parker, CFO: other filings, last Jul 9, 2026
- Charles David Pauza, C-suite exec: other filings, last Jul 9, 2026
- Orbimed Advisors LLC, 10% owner: bought $4M (2 buys), last Apr 16, 2026
Get free alerts when an insider at Traws Pharma, Inc files a new trade →